Skip to content
Business Company News, Medical Health Aged Care

The Hon Gabrielle Upton joins the Florey Board

- 2 mins read

The Florey is pleased to announce the appointment of the Hon Gabrielle Upton to its Board of Directors. 

Ms Upton has had a distinguished career as a lawyer, banker, government minister and university Deputy Chancellor. 

She was New South Wales’ first female Attorney General, is a Board Member of Netball Australia, and serves as an Advisory Board Member of the Australian Research Council Centre of Excellence of Quantum Biotechnology.  

The Florey’s Board Chair, Mr Martin Adams, welcomed Ms Upton to the Board.   

“Gabrielle is a leader who brings a wealth of experience to The Florey. She has extensive knowledge of medical research, neuroscience and higher education, having previously served on the board of Neuroscience Research Australia (NeuRA) and as Deputy Chancellor of the University of New South Wales,” Mr Adams said. 

“The Florey is building momentum, working at the frontier of neuroscience and mental health. Our work is transforming lives and communities here in Australia and around the world. It’s an exciting time for Gabrielle to be joining the Florey, and we are delighted to have her as a member of the Board. 

Ms Upton said she was excited to join The Florey board.  

“The Florey has a distinguished history and bright future finding the causes and cures for diseases affecting the brain – the least understood part of our body. I particularly look forward to supporting its work to improve the lives of people living with brain and mental health conditions,” she said.

 


About us:

The Florey is Australia’s leading brain research institute with a focus on improving the lives of people with neurological and psychiatric conditions. The Florey’s research missions are centred around dementiaepilepsymental health and developing ways to protect and repair the brain. These missions are strengthened by The Florey’s expertise in neurotherapeutics, neuroimaging, synaptic biology and systems neuroscience. With 600 researchers, The Florey is the largest research centre of its kind in the southern hemisphere.

Find out more about us on our website: www.florey.edu.au


Contact details:

Kathryn Powley, Media and Communications Manager

[email protected] | 0456 666 271

Media

More from this category

  • Medical Health Aged Care
  • 22/01/2026
  • 03:41
Galderma

Galderma Provides Update on Arbitration Case Regarding Neuromodulator Research and Development Partnership

ZUG, Switzerland–BUSINESS WIRE– Galderma (SIX:GALD), the pure-play dermatology category leader, today announced that an International Chamber of Commerce arbitral tribunal issued an award confirming…

  • Contains:
  • Medical Health Aged Care
  • 21/01/2026
  • 20:10
Ramsay Health Care

St George Private Hospital begins $16.4m expansion to strengthen patient care

Key Facts: $16.4m expansion project at St George Private Hospital (Sydney) will add 2 fully equipped operating theatres plus 2 future theatre spaces Project…

  • Contains:
  • Medical Health Aged Care
  • 21/01/2026
  • 19:41
Angelini Pharma

Angelini Pharma Announces Appointment of Sergio Marullo di Condojanni as New CEO

CEO of family company Angelini Industries will also lead the pharmaceutical company from today, bringing strong leadership experience and strategic visionROME, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Angelini Pharma, part of the multinational privately owned industrial group Angelini Industries, today announced the appointment of Sergio Marullo di Condojanni as Chief Executive Officer. He has served as CEO of Angelini Industries since 2020 and will maintain that role while assuming leadership of the pharmaceutical division to drive cohesive strategy implementation, leveraging extensive executive, governance, and financial expertise. Jacopo Andreose, who led Angelini Pharma until the end of 2025, will become a…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.